AMP German Cannabis Group Announces Non-Brokered Placement Private Placement to Fund German Medical Cannabis Import Business
BERLIN, Germany, January 8, 2020 – AMP German Cannabis Group Inc. (“AMP” or the “Company”) (CSE: XCX) (FSE: C4T, ISIN: CA00176G1028) announces a non-brokered placement of up to 8,000,000 common shares of the Company at a price of $0.25 per share for gross proceeds of up to $2,000,000.
The Company intends to use the net proceeds from the offering to fund its import business, general corporate purposes and working capital. All securities issued pursuant to the offering will be subject to a statutory hold period of four months plus a day from issuance in accordance with applicable securities laws.
In connection with the offering, the Company may pay a finder’s fee and warrants to one or more arm’s length parties.
About AMP German Cannabis Group Inc.
AMP German Cannabis Group is a specialized importer of EU-GMP medical cannabis from European and non-European countries into Germany. For more information, please visit: www.amp-eu.com.
Mr. Alex Blodgett, CEO and Director
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the shares in the United States. The shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
This news release contains forward-looking statements that are based on the Company’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the completion of the offering, the timing thereof and the expected use of proceeds from the offering. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.
SOURCE AMP German Cannabis Group Inc.